Patents by Inventor Jianquan Zheng

Jianquan Zheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10889575
    Abstract: The invention belongs to the field of medicine and chemical industry and relates to a 4,4-diphenylpiperidine compound or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same and uses thereof. In particular, the invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, and to a pharmaceutical composition comprising the compound or a pharmaceutically acceptable salt thereof. In the present invention, the compound or pharmaceutically acceptable salt thereof and the pharmaceutical composition have significant activity in blocking an N-type calcium channel, and have good pharmacokinetic properties, can effectively relieve pain, and have a potential as a new medicament for prevention or treatment of pain, stroke, cerebral ischemia, alcohol addiction, alcoholism, kidney disease, addictive disorder caused by analgesic or tolerance disorder caused by analgesic.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: January 12, 2021
    Assignee: Academy of Military Medical Sciences
    Inventors: Cheng Zhang, Haoshan Wang, Guoxing Dong, Ning Wu, Shuzhuo Zhang, Xiaomei Zhuang, Chong Pang, Juan Wang, Rifang Yang, Jianquan Zheng, Jin Li, Liuhong Yun
  • Patent number: 10740520
    Abstract: The disclosure relates to a method, computer program product or data processing system for performing graph-based static timing analysis, GBA, of an integrated circuit design having a set of timing paths. The method comprises identifying a subset of the set of timing paths and performing path-based analysis, PBA, of the subset of timing paths to determine at least one PBA timing parameter for each timing path of the subset of timing paths. The method further comprises determining at least one optimized GBA timing parameter for at least one timing path of the subset of timing paths by minimizing a function that is based on a difference between the at least one optimized GBA timing parameter and the at least one PBA timing parameter of the at least one timing path.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: August 11, 2020
    Assignee: Synopsys, Inc.
    Inventors: Chunyang Feng, Jianquan Zheng, Fulin Peng
  • Publication number: 20200026812
    Abstract: The disclosure relates to a method, computer program product or data processing system for performing graph-based static timing analysis, GBA, of an integrated circuit design having a set of timing paths. The method comprises identifying a subset of the set of timing paths and performing path-based analysis, PBA, of the subset of timing paths to determine at least one PBA timing parameter for each timing path of the subset of timing paths. The method further comprises determining at least one optimized GBA timing parameter for at least one timing path of the subset of timing paths by minimizing a function that is based on a difference between the at least one optimized GBA timing parameter and the at least one PBA timing parameter of the at least one timing path.
    Type: Application
    Filed: April 14, 2017
    Publication date: January 23, 2020
    Applicant: Synopsys, Inc.
    Inventors: Chunyang Feng, Jianquan Zheng, Fulin Peng
  • Publication number: 20190359604
    Abstract: The invention belongs to the field of medicine and chemical industry and relates to a 4,4-diphenylpiperidine compound or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same and uses thereof. In particular, the invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, and to a pharmaceutical composition comprising the compound or a pharmaceutically acceptable salt thereof. In the present invention, the compound or pharmaceutically acceptable salt thereof and the pharmaceutical composition have significant activity in blocking an N-type calcium channel, and have good pharmacokinetic properties, can effectively relieve pain, and have a potentialas a new medicament for prevention or treatment of pain, stroke, cerebral ischemia, alcohol addiction, alcoholism, kidney disease, addictive disorder caused by analgesic or tolerance disorder caused by analgesic.
    Type: Application
    Filed: January 12, 2018
    Publication date: November 28, 2019
    Applicant: Academy of Military Medical Sciences
    Inventors: Cheng Zhang, Haoshan WANG, Guoxing DONG, Ning WU, Shuzhuo ZHANG, Xiaomei ZHUANG, Chong PANG, Juan WANG, Rifang YANG, Jianquan ZHENG, Jin LI, Liuhong YUN
  • Patent number: 10387606
    Abstract: A computer implemented method for validating a clock tree includes estimating a first number of a multitude of first buffers disposed in the clock tree path, and selecting a first scaling coefficient in accordance with the first number. The computer implemented method further includes scaling a first delay associated with the multitude of first buffers in accordance with the selected first scaling coefficient, and generating a second multitude of second buffers disposed in the clock tree path defined by a second number greater than the first number.
    Type: Grant
    Filed: May 3, 2016
    Date of Patent: August 20, 2019
    Assignee: SYNOPSYS, INC.
    Inventors: Chunyang Feng, Jianquan Zheng
  • Publication number: 20170004249
    Abstract: A computer implemented method for validating a clock tree includes estimating a first number of a multitude of first buffers disposed in the clock tree path, and selecting a first scaling coefficient in accordance with the first number. The computer implemented method further includes scaling a first delay associated with the multitude of first buffers in accordance with the selected first scaling coefficient, and generating a second multitude of second buffers disposed in the clock tree path defined by a second number greater than the first number.
    Type: Application
    Filed: May 3, 2016
    Publication date: January 5, 2017
    Inventors: Chunyang FENG, Jianquan Zheng
  • Patent number: 8080522
    Abstract: Polyethylene glycol modifications of thymosin alpha 1 (T&agr; 1-PEGs), their preparation process, the medicine composition containing them, and their application in the medicine for preventing and treating diseases related with immune deficiency and hypoimmunity, including hepatitis B, hepatitis C, hepatoma, malignant melanoma, non-small cell lung cancer, SARS, and AIDS etc.
    Type: Grant
    Filed: November 11, 2006
    Date of Patent: December 20, 2011
    Assignee: Institute of Pharmacology and Toxicology Academy of Military Mecical Sciences, P.L.A., China
    Inventors: Keliang Liu, Jiankun Qie, Jinbo Ma, Jianquan Zheng, Sijian Dong, Wenxia Zhou, Chunhui Qi
  • Publication number: 20110306633
    Abstract: The present invention provides a selective M4 receptor antagonist, levorotatory demethylated phencynonate or its nontoxic pharmaceutically acceptable salt, a pharmaceutical composition comprising this compound, and a use thereof in the manufacture of a medicament for the treatment of motion dysfunction, such as, tremor, rigor and the like caused by Parkinson's disease (PD).
    Type: Application
    Filed: November 7, 2007
    Publication date: December 15, 2011
    Applicant: INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A.CHINA
    Inventors: Bohua Zhong, Jianquan Zheng, Liyun Wang, He Liu, Lanfu Chen, Keliang Liu
  • Publication number: 20090221487
    Abstract: Polyethylene glycol modifications of thymosin alpha 1 (T&agr; 1-PEGs), their preparation process, the medicine composition containing them, and their application in the medicine for preventing and treating diseases related with immune deficiency and hypoimmunity, including hepatitis B, hepatitis C, hepatoma, malignant melanoma, non-small cell lung cancer, SARS, and AIDS etc.
    Type: Application
    Filed: November 11, 2006
    Publication date: September 3, 2009
    Applicant: Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
    Inventors: Keliang Liu, Jiankun Qie, Jinbo Ma, Jianquan Zheng, Sijian Dong, Sijian Dong, Wenxia Zhou, Chunhui Qi
  • Patent number: D989360
    Type: Grant
    Filed: February 16, 2023
    Date of Patent: June 13, 2023
    Assignee: Shenzhen BoXinRui Electronic Co Ltd
    Inventor: Jianquan Zheng